cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Docusign Inc
275 own
148 watching
Current Price
$0
$-0.72
(-1.07%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
13,638.51M
52-Week High
52-Week High
131.9074
52-Week Low
52-Week Low
39.57
Average Volume
Average Volume
1.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization13,638.51M
icon52-Week High131.9074
icon52-Week Low39.57
iconAverage Volume1.02M
iconDividend Yield--
iconP/E Ratio--
What does the Docusign Inc do?
N/A
Read More
How much money does Docusign Inc make?
News & Events about Docusign Inc.
PR Newswire
4days ago
DocuSign expands leadership team with newly created roles across strategy, marketing & growth DocuSign expands leadership team with newly created roles across strategy, marketing & growth PR Newswire SAN FRANCISCO, Jan. 30, 2023 Seasoned marketing and operational leaders from...
Ticker Report
8days ago
DocuSign, Inc. (NASDAQ:DOCU Get Rating) Director Daniel D. Springer sold 147,008 shares of DocuSign stock in a transaction dated Thursday, January 19th. The shares were sold at an average price of $55.08, for a total value of $8,097,200.64. Following the completion of the transaction, the ...
Zolmax
12days ago
DocuSign, Inc. (NASDAQ:DOCU Get Rating) Director Daniel D. Springer sold 147,009 shares of the stock in a transaction on Tuesday, January 17th. The stock was sold at an average price of $58.48, for a total value of $8,597,086.32. Following the sale, the director now owns 1,524,335 shares of the ...
PR Newswire
29days ago
Thinking about trading options or stock in Biomarin Pharmaceutical, Docusign, Apple, MicroStrategy, or Allstate Corp? Thinking about trading options or stock in Biomarin Pharmaceutical, Docusign, Apple, MicroStrategy, or Allstate Corp? PR Newswire NEW YORK, Jan. 5, 2023 NEW YORK, Jan. 5, 2023...
Zolmax
1month ago
DocuSign (NASDAQ:DOCU Get Rating) had its price target upped by Citigroup from $59.00 to $72.00 in a research report report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. Several other equities research analysts have also weighed in on the company. ...
Frequently Asked Questions
Frequently Asked Questions
What is Docusign Inc share price today?
plus_minus_icon
Can Indians buy Docusign Inc shares?
plus_minus_icon
How can I buy Docusign Inc shares from India?
plus_minus_icon
Can Fractional shares of Docusign Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Docusign Inc stocks?
plus_minus_icon
What is today’s traded volume of Docusign Inc?
plus_minus_icon
What is today’s market capitalisation of Docusign Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Docusign Inc?
plus_minus_icon
What percentage is Docusign Inc down from its 52-Week High?
plus_minus_icon
What percentage is Docusign Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.72
(-1.07%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00